Literature DB >> 3384522

Psychopathology in mountaineering--mental disturbances under high-altitude stress.

Z Ryn1.   

Abstract

In the years 1960-1985 psychiatric and psychological research was conducted among a group of 80 Polish alpinists. Experimental research was conducted during the expeditions to the Hindu Kush mountains and to the Andes (1971, 1973-74, 1979, 1985). The aim of the research was to describe the personality of the alpinists, their motivation, as well as mental disturbances caused by staying at high altitudes. On the basis of an interview and the Cattell personality questionnaire, two types of personality were distinguished: the schizoid-psychasthenic type (53 persons, i.e. 66%) and the asthenic-neurotic type (23 persons, i.e. 30%). As regards the motivation for mountain climbing, situational and personality factors were described, among them, the need to experience "powerful situations" and compensating for an inferiority complex. A so called integrational fear which mobilizes the psychophysical capabilities to overcome the hardships of the climb, was described as characteristic of the alpinists. Depending on the altitude and the duration of one's stay at it, the mental disturbances, in most cases took on the form of the neurasthenic syndrome (asthenic or sthenic) at low altitudes (3000-4000 m), the cyclothymic syndrome at medium altitudes (4000-5000 m), and the acute organic brain syndrome at high altitudes (above 7000 m). In 24 (35%) cases, there occurred psychotic disturbances with profound disturbances of consciousness and orientation. These states were accompanied by symptoms of high-altitude deterioration with a break-down in the physical condition, disturbances in the hydro-electrolyte equilibrium, and a considerable loss of bodily weight.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3384522     DOI: 10.1055/s-2007-1024998

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  8 in total

Review 1.  Neuropsychological functioning associated with high-altitude exposure.

Authors:  Javier Virués-Ortega; Gualberto Buela-Casal; Eduardo Garrido; Bernardino Alcázar
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

Review 2.  Effects of altitude on mood, behaviour and cognitive functioning. A review.

Authors:  M S Bahrke; B Shukitt-Hale
Journal:  Sports Med       Date:  1993-08       Impact factor: 11.136

3.  New evidence from magnetic resonance imaging of brain changes after climbs at extreme altitude.

Authors:  E Garrido; R Segura; A Capdevila; J Aldomá; F A Rodríguez; C Javierra; J L Ventura
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

4.  Isolated psychosis during exposure to very high and extreme altitude - characterisation of a new medical entity.

Authors:  Katharina Hüfner; Hermann Brugger; Eva Kuster; Franziska Dünsser; Agnieszka E Stawinoga; Rachel Turner; Iztok Tomazin; Barbara Sperner-Unterweger
Journal:  Psychol Med       Date:  2017-12-05       Impact factor: 7.723

5.  Going to Altitude with a Preexisting Psychiatric Condition.

Authors:  Katharina Hüfner; Barbara Sperner-Unterweger; Hermann Brugger
Journal:  High Alt Med Biol       Date:  2019-07-25       Impact factor: 1.981

6.  Chronic Exposure to High Altitude: Synaptic, Astroglial and Memory Changes.

Authors:  Rupali Sharma; Nathan P Cramer; Bayley Perry; Zahra Adahman; Erin K Murphy; Xiufen Xu; Bernard J Dardzinski; Zygmunt Galdzicki; Daniel P Perl; Dara L Dickstein; Diego Iacono
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

Review 7.  Recommendations for traveling to altitude with neurological disorders.

Authors:  Marika Falla; Guido Giardini; Corrado Angelini
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20

8.  Assessment of Psychotic Symptoms in Individuals Exposed to Very High or Extreme Altitude: A Field Study.

Authors:  Katharina Hüfner; Fabio Caramazza; Agnieszka E Stawinoga; Evelyn R Pircher Nöckler; Paolo Fusar-Poli; Sanjeeb S Bhandari; Buddha Basnyat; Monika Brodmann Maeder; Giacomo Strapazzon; Iztok Tomazin; Barbara Sperner-Unterweger; Hermann Brugger
Journal:  High Alt Med Biol       Date:  2021-07-29       Impact factor: 1.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.